1. X
  2. Jonathan Spicer MD PhD
Log inSign up
Jonathan Spicer MD PhD
5,571 posts
Image
user avatar
Jonathan Spicer MD PhD
@DoctorJSpicer
Medical Director of the McGill Thoracic Oncology Program; Chest surgeon; Neutrophil biologist; Cancer immunologist; Aspiring farmer
Montréal, Québec
thoracicsurgery.lab.mcgill.ca/jonathan-spice…
Joined May 2011
1,073
Following
4,410
Followers
RepliesRepliesMediaMedia

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • Pinned
    user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    Sep 14, 2024
    KN671 OS and HRQoL! Check it out: sciencedirect.com/science/articl…
    Image
    26K026K
  • user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    Apr 23, 2020
    No joke - we had a patient swallow Lysol as a #disinfectant a couple of weeks ago to prevent COVID19 infection. He made it out of the hospital after his gastrectomy... This kind of nonsense is absolutely mind blowing.
    Image
    user avatar
    Aaron Rupar
    00:00
    user avatar
    Aaron Rupar
  • user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    Oct 29, 2025
    Quel imbécile ce @francoislegault! Comme si c’était la faute du PM de l’Ontario que les médecins québécois cherchent à quitter. Il faut vraiment être abrutit pour penser que les professionnels les plus éduqués de la province seraient prisonniers d’une province qui les maltraite.
    user avatar
    Sébastien Bovet
    @SebBovetSRC
    Oct 29, 2025
    Nouveau Doug Ford qui invite les médecins québécois à venir en Ontario est un « manque de jugement total et inacceptable » selon ⁦@francoislegault⁩ #polqc #polcan
    Image
    20K020K
  • user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    Jul 6, 2023
    Hard to believe but after 8 long years, the Spicer lab @RIMUHC1 finally has @CIHR_IRSC funding! Thank you to my amazing collaborators @DanielaQuail @loganawalsh @McGillGCI, Dr Morgan Craig @UMontreal. Never possible without the amazing stewardship of @ronirayes from the start!
    15K015K
  • user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    Apr 11, 2022
    Here it is folks! #LCSM #AACR22
    Image
    nejm.org
    Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer | NEJM
    Neoadjuvant or adjuvant chemotherapy confers a modest benefit over surgery alone for resectable non–small-cell lung cancer (NSCLC). In early-phase trials, nivolumab-based neoadjuvant regimens have ...
  • user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    Mar 30, 2023
    T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants. Hot stuff coming out in ⁦@CellCellPress⁩ on #neutrophils and #immunotherapy!
    Image
    T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants
    From cell.com
    13K013K
  • user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    Nov 5, 2025
    L’homme sur lequel j’ai calqué ma carrière et qui a servi de mentor à tant de chirurgiens talentueux sur une période de 50 ans l’explique mieux que personne. Dr David Mulder parle d’une époque où le Québec fut un pôle recruteur et il en est l’exemple classique. Un jeune homme
    Image
    Loi 2 | Nos hôpitaux et nos communautés en danger
    From lapresse.ca
    49K049K
  • user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    Jun 4, 2025
    Why is CM816 so important? After @FordePatrick beautiful presentation of these revolutionary data, let’s dig into why this unique trial should shake up our vision for oncology research…
    Image
    17K017K
  • user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    Jun 3, 2023
    Just like CM816, for those saying there is no OS effect, I ask you which curve do you prefer for your patients? Let’s just give it a bit of time, eh? @NEJM @ASCO @IASLC @AATSHQ @thoracic @ThoracicsCanada #ASCO23 nejm.org/doi/full/10.10…
    Image
    29K029K
  • user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    May 17, 2023
    Exciting list in the OR today! Case #1: post-NeoADAURA stage IIA Case #2: post-chemo+Nivo stage IIA Case #3: post-NeoCOAST2 stage IIIA Thrilled to be operating with our fellow @bulgalucho! @MThoracics @cusm_muhc @CodeVie_Life @CedarsCancer #LCSM
    Image
    6.2K06.2K
  • user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    Jun 3, 2023
    A beautiful lung cancer paper by @JonesDavid2013 and @MSK_Thoracic team! A key finding is that only 4% of metastatic lesions harbour actionable mutations not previously identified in the primary - an important argument for molecular testing in early stage!
    Image
    Genomic mapping of metastatic organotropism in lung adenocarcinoma
    From cell.com
    11K011K
  • user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    Oct 29, 2025
    To any health care institution or headhunter seeking world-class physicians and surgeons, the Quebec legistlature has passed a new special law severly impacting the civil and professional liberties of medical practitioners in our province, where average remuneration was already
    39K039K
  • user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    Oct 23, 2023
    #ALINA, #ADAURA and #KN671 were all smiles today @myESMO #ESMO23! Love these guys!
    Image
    5.1K05.1K
  • user avatar
    Jonathan Spicer MD PhD
    @DoctorJSpicer
    Jun 4, 2025
    It seems we are in a bit of a data quagmire. I often get asked how to choose between neoadjuvant versus perioperative immunotherapy and right now there aren’t many great answers, but for what it’s worth, here’s my general perspective… #ASCO25
    Image
    Image
    16K016K
Advertisement
Advertisement